Background The early establishment of infarct artery reperfusion by intravenous thrombolytic therapy has improved survival after acute myocardial infarction. Investigations of reperfusion have focused on the effects of specific thrombolytic agents, anticoagulation, and platelet inhibition. However, little attention has been given to the relation of arterial blood pressure to thrombolysis, a factor that probably affects thrombolytic agent delivery to the obstructing thrombus.
IABP and Coronary Flow Velocity
Five animals did not undergo coronary thrombosis (group 4) and had coronary blood flow velocity determined before and after IABP. The method of balloon catheter insertion was identical to group 3. Phasic blood flow velocity, mean velocity, aortic pressure, heart rate, and ECG were measured before and after the formation of critical stenosis. Critical stenosis was defined as in groups 1 through 3. Balloon inflation and deflation were performed as in group 3.
Statistical Analysis
All measurements are presented as a mean±SEM. At 0, 30, 60, 90, 120, and 150 minutes, each animal's heart rate, systolic blood pressure, and diastolic blood pressure were adjusted by subtracting the respective baseline measurements. To test for significant changes in heart rate, systolic, and diastolic blood pressures between groups, a nonparametric one-way ANOVA was used (Statistical Analysis System NPARlWAY procedure). This was performed at each of the time points. A Wilcoxon rank-sum statistic (correcting for continuity) was computed for these as well as for number of reocclusions, reperfusion time, time to initial reocclusion, and total flow duration measurements.
Results

Effect of IABP on Coronary Flow Velocity
In the absence or presence of LAD stenosis, IABP had no effect on mean LAD flow velocity as studied in group 4 dogs (98.0±3.7% of baseline, P=.55, and 96.6±1.8% of baseline, P=.13, respectively). As shown in a representative animal before stenosis formation (Fig 2) , LAD peak flow velocity increases slightly immediately after turning the IABP on. However, by the sixth cardiac cycle, there is no difference compared with baseline. After the formation of a "critical" stenosis in the same animal, LAD peak flow velocity also transiently rises after IABP but then falls toward baseline (Fig 3) . Hemodynamic Observations in Animals Receiving Thrombolytic Therapy Heart rate was similar throughout the experiment in groups 2 and 3. Systolic arterial pressure remained similar between these groups throughout the experiment (Fig 4) . With IABP, peak diastolic blood pressure in group 3 animals remained significantly higher than the diastolic pressure in group 2 animals (Fig 5) . Previous investigations have shown that IABP reduces reocclusion in humans after angioplasty in acute myocardial infarction.14 However, reocclusion and total duration of coronary blood flow were not significantly affected by the IABP in our study. In this type of animal model of coronary thrombosis, it has been demonstrated that platelet aggregation is the primary event causing reocclusion.10 It is possible that a potentially favorable effect of aortic pressure augmentation on maintenance of reperfusion was offset by platelet activation caused by the balloon pump itself.'5 In our model, animals received no heparin or antiplatelet therapy, both of which could have affected the incidence of reocclusion. 16 The effect of heparin on reperfusion after accelerated rTPA in this type of model is unknown. The goal of the study was to determine a possible relation between diastolic pressure augmentation and the establishment of reperfusion by rTPA. The combination of heparin and LABP may have important effects on reocclusion; however, the current investigation was not designed to determine these effects.
The findings of this study may have particular relevance to the treatment of acute myocardial infarction associated with a depressed hemodynamic profile. In this subgroup of patients, intravenous thrombolytic therapy has not been beneficial. 8 It has been postulated that the low patency rates achieved explain this lack of benefit. The demonstration that arterial pressure augmentation facilitates arterial opening, an event believed to be critical for survival in shock, may therefore have especially important implications for therapy in these patients.
Conclusions
Intra-aortic balloon counterpulsation enhances reperfusion by thrombolytic therapy in this canine model of coronary thrombosis. We hypothesize that this phenomenon is mediated by a primary mechanical effect of the augmented diastolic pressure wave and not by augmentation of coronary blood flow. This is the first study that demonstrates that arterial pressure augmentation facilitates the opening of thrombotically occluded coronary arteries by thrombolytic therapy and suggests that reperfusion with rTPA may be blood pressure dependent. These findings have important implications for future myocardial infarction therapies, particularly in the setting of hypotension and shock. Further studies are needed to investigate the effect of pharmacological regulation of arterial blood pressure during thrombolysis.
